Discovery during the livestream 9-17 Bio Protocol's OTC (off-the-counter) 9-17 Bio Protocol @BioProtocol completed an OTC deal worth $6.9 million. The investment came from Arthur Hayes @CryptoHayes' family office, Mechanism Capital @MechanismCap, Animoca, Mirana, Foresight, and other funds. According to the disclosure, the funds are intended to support their AI-native decentralized science platform (DeSci + AI), accelerating progress in scientific research, drug discovery, and more. But I remain skeptical. The estimated OTC cost is around $0.10. Recent accumulation range is around $0.14-$0.15. Current price: $0.175. OI (open interest) is currently at a low point, and funding rates have been negative for a long time, indicating a large number of hedging positions. There might be some trading opportunities here. ————————————————————